Devroe Eric (CIK 1950573) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-20). Recent activity: Sell ACRV (604 shares), Buy ACRV (72,981 shares), Sell ACRV (613 shares), Sell ACRV (723 shares), Buy ACRV (10,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-20 | Acrivon Therapeutics, Inc. (ACRV) | Chief Operating Officer | Sell | 604 | $1,214 |
| 2026-05-20 | Acrivon Therapeutics, Inc. (ACRV) | Chief Operating Officer | Buy | 72,981 | $0 |
| 2026-05-18 | Acrivon Therapeutics, Inc. (ACRV) | Chief Operating Officer | Sell | 613 | $1,177 |
| 2026-02-18 | Acrivon Therapeutics, Inc. (ACRV) | Chief Operating Officer | Sell | 723 | $1,178 |
| 2026-01-15 | Acrivon Therapeutics, Inc. (ACRV) | Chief Operating Officer | Buy | 10,000 | $17,200 |
| 2025-11-18 | Acrivon Therapeutics, Inc. (ACRV) | Chief Operating Officer | Sell | 613 | $1,373 |
| 2025-08-18 | Acrivon Therapeutics, Inc. (ACRV) | Chief Operating Officer | Sell | 613 | $852 |
| 2025-05-16 | Acrivon Therapeutics, Inc. (ACRV) | Chief Operating Officer | Sell | 613 | $699 |
Source: SEC Form 4 filings · as of 2026-08-20